224
Participants
Start Date
May 31, 2013
Primary Completion Date
December 31, 2017
Study Completion Date
June 4, 2018
Gefitinib and Metformin
Gefitinib will be administered once every day. If subject has complete response, partial response, stable disease, or unacceptable toxicity.
Gefitinib and placebo
Gefitinib will be administered once every day. If subject has complete response, partial response, stable disease, or unacceptable toxicity.
Department of Respiratory Diseases, Daping Hospital, Third Military Medical University, Chongqing
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
OTHER